Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changes in peripheral immune cells after intraoperative radiation therapy in low-risk breast cancer.
Linares-Galiana I, Berenguer-Frances MA, Cañas-Cortés R, Pujol-Canadell M, Comas-Antón S, Martínez E, Laplana M, Pérez-Montero H, Pla-Farnós MJ, Navarro-Martin A, Nuñez M, Both B, Guedea F. Linares-Galiana I, et al. Among authors: laplana m. J Radiat Res. 2021 Jan 1;62(1):110-118. doi: 10.1093/jrr/rraa083. J Radiat Res. 2021. PMID: 33006364 Free PMC article.
Advantages of intraoperative implant for interstitial brachytherapy for accelerated partial breast irradiation either frail patients with early-stage disease or in locally recurrent breast cancer.
Cozzi S, Laplana M, Najjari D, Slocker A, Encinas X, Pera J, Guedea F, Gutierrez C. Cozzi S, et al. Among authors: laplana m. J Contemp Brachytherapy. 2018 Apr;10(2):97-104. doi: 10.5114/jcb.2018.75594. Epub 2018 Apr 30. J Contemp Brachytherapy. 2018. PMID: 29789758 Free PMC article.
Second breast-conserving therapy with interstitial brachytherapy (APBI) as a salvage treatment in ipsilateral breast tumor recurrence: a retrospective study of 40 patients.
Cozzi S, Jamal DN, Slocker A, Laplana M, Tejedor AG, Krengli M, Guedea F, Gutierrez C. Cozzi S, et al. Among authors: laplana m. J Contemp Brachytherapy. 2019 Apr;11(2):101-107. doi: 10.5114/jcb.2019.84689. Epub 2019 Apr 29. J Contemp Brachytherapy. 2019. PMID: 31139217 Free PMC article.
Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?
Garcia-Tejedor A, Fernandez-Gonzalez S, Ortega R, Gil-Gil M, Perez-Montero H, Fernandez-Montolí E, Stradella A, Recalde S, Soler T, Petit A, Bajen MT, Benitez A, Guma A, Campos M, Pla MJ, Martinez E, Laplana M, Pernas S, Perez-Sildekova D, Catala I, Ponce J, Falo C. Garcia-Tejedor A, et al. Among authors: laplana m. Breast Cancer Res Treat. 2021 Feb;185(3):657-666. doi: 10.1007/s10549-020-05970-2. Epub 2020 Oct 17. Breast Cancer Res Treat. 2021. PMID: 33068198
The effect of omitting axillary dissection and the impact of radiotherapy on patients with breast cancer sentinel node macrometastases: a cohort study following the ACOSOG Z0011 and AMAROS trials.
Ortega Expósito C, Falo C, Pernas S, Pérez Carton S, Gil Gil M, Ortega R, Pérez Montero H, Stradella A, Martinez E, Laplana M, Salinas S, Luzardo A, Soler T, Fernández Montoli ME, Azcarate J, Guma A, Petit A, Benitez A, Bajen M, Reyes Junca JG, Campos M, Ruiz R, Ponce J, Pla MJ, García Tejedor A. Ortega Expósito C, et al. Among authors: laplana m. Breast Cancer Res Treat. 2021 Aug;189(1):111-120. doi: 10.1007/s10549-021-06274-9. Epub 2021 Jun 4. Breast Cancer Res Treat. 2021. PMID: 34089119
Effectiveness and safety of intraoperative radiotherapy (IORT) with low-energy X-rays (INTRABEAM®) for accelerated partial breast irradiation (APBI).
Laplana M, García-Marqueta M, Sánchez-Fernández JJ, Martínez-Pérez E, Pérez-Montero H, Martínez-Montesinos I, Eraso A, Saldaña P, Martín R, Martín MI, Pla MJ, García-Tejedor A, Guedea F. Laplana M, et al. Clin Transl Oncol. 2022 Sep;24(9):1732-1743. doi: 10.1007/s12094-022-02823-w. Epub 2022 Mar 19. Clin Transl Oncol. 2022. PMID: 35305245
Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial).
Garcia-Tejedor A, Ortega-Exposito C, Salinas S, Luzardo-González A, Falo C, Martinez-Pérez E, Pérez-Montero H, Soler-Monsó MT, Bajen MT, Benitez A, Ortega R, Petit A, Guma A, Campos M, Plà MJ, Pernas S, Peñafiel J, Yeste C, Gil-Gil M, Guedea F, Ponce J, Laplana M. Garcia-Tejedor A, et al. Among authors: laplana m. Front Oncol. 2023 Aug 9;13:1184021. doi: 10.3389/fonc.2023.1184021. eCollection 2023. Front Oncol. 2023. PMID: 37621686 Free PMC article.
34 results